
ADMA Biologics, Inc.
USD8.38
+0.01 (+0.12%)
CEO
Adam S. Grossman
IPO Date
2013-10-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.49
Prev. Close
$8.37
Day Low
$8.29
Day High
$8.53
52W Low
$7.21
52W High
$20.46
Market Cap
$1.94B
Volume
1.00M
| 26 Mar 2026 |
| Cantor Fitzgerald |
| Overweight |
| Neutral |
| downgrade |
| 8 May 2025 | Raymond James | Strong Buy | Strong Buy | maintain |
| 4 Mar 2025 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 8 Nov 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Nov 2024 | Raymond James | Strong Buy | Strong Buy | maintain |
| 14 Oct 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |